Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Insulin Resistance × DLBS3233 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Insulin Resistance 1

Interventions

Metformin 17 Inositol 5 Pioglitazone 3 Exercise 3 Ethinyl Estradiol 3 drospirenone and ethinyl estradiol combination 2 Surveys and Questionnaires 2 Insulin 2 Cyproterone Acetate 2 Acupuncture Therapy 2 ziprasidone 1 salicylsalicylic acid 1 maltodextrin 1 licogliflozin 1 drospirenone 1 cinnulin PF 1 Zoledronic Acid 1 Waist-Hip Ratio 1 Waist Circumference 1 Vitamin D 1 Time 1 Thioctic Acid 1 Tablets 1 Sulfasalazine 1 Sugars 1 Sodium-Glucose Transporter 2 Inhibitors 1 Sodium Salicylate 1 Saline Solution 1 Resistance Training 1 Preoperative Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01999686 2019-05-28

POSITIF

Dexa Medica Group

Phase 3 Completed

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡